Results 131 to 140 of about 2,825 (179)

Optical coherence tomography guidance during bioresorbable vascular scaffold implantation. [PDF]

J Thorac Dis, 2017
Secco GG, Verdoia M, Pistis G, De Luca G, Vercellino M, Audo A, Parisi R, Reale M, Ballestrero G, Marino PN, Di Mario C.   +10 more
europepmc   +1 more source

Balloon postdilatation is a mandatory step in the deployment of bioresorbable vascular scaffold. [PDF]

Anatol J Cardiol, 2017
Karabulut A.
europepmc   +1 more source

Very late bioresorbable vascular scaffold thrombosis at 25 months post implantation. [PDF]

Singapore Med J, 2017
Chan KH, Seow SC, Tan HC.
europepmc   +1 more source

Iron-Based Bioresorbable Scaffold in Contemporary: A Viewpoint on Design Rationale, Early Evidence, and Unresolved Questions. [PDF]

JACC Asia
Cheng S, Sheng W, Liu X, Wang J.
europepmc   +1 more source

Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up: A Systematic Meta-analysis and Individual Patient Data Pooled Study.

JAMA Cardiol, 2019
Stone GW, Kimura T, Gao R, Kereiakes DJ, Ellis SG, Onuma Y, Chevalier B, Simonton C, Dressler O, Crowley A, Ali ZA, Serruys PW.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Looking into the future with bioresorbable vascular scaffolds

Expert Review of Cardiovascular Therapy, 2013
Bioresorbable scaffold technology has evolved over the last few years with a number of devices either available or under clinical and preclinical investigation. The absence of a permanent metallic segment in the treated vessel wall has the potential to address some of the issues still encountered with metallic drug-eluting stents despite improvements ...
Charis, Costopoulos, Toru, Naganuma, Azeem, Latib, Antonio, Colombo   +3 more
openaire   +2 more sources

Fracture with the newer bioresorbable vascular scaffolds

Catheterization and Cardiovascular Interventions, 2017
Bioresorbable vascular scaffolds (BVS) are being increasingly used in complex, real‐world lesions. The possibility of strut fractures is a rare entity with the use of drug eluting stents (DES), but has not yet been adequately described for the BVS technology.
Mostafa Elwany, Gaetano Di Palma, Bernardo Cortese   +2 more
openaire   +2 more sources

Bioresorbable Vascular Scaffolds in Interventional Neuroradiology

Clinical Neuroradiology, 2017
Bioresorbable vascular scaffolds (BVS) have changed practice patterns in cardiology. These resorbable stents have not yet been utilized in the cerebrovascular circulation. We report the initial experiences with these devices in interventional neuroradiology.A retrospective review of clinical presentations, imaging findings and follow-up results of all ...
Anil Arat, Ergun Daglioglu, Ilkay Akmangit, Ahmet Peker, Murat Arsava, Mehmet Akif Topcuoglu, Deniz Belen   +6 more
openaire   +2 more sources

Delivery of a bioresorbable vascular scaffold to complex lesions

Catheterization and Cardiovascular Interventions, 2014
The use of bioresorbable vascular scaffolds (BVS) in percutaneous coronary interventions holds great promise and the Absorb® BVS is increasingly used in clinical practice outside of controlled studies. However, questions have been raised concerning the delivery of the scaffold to complex lesions.
Felix, Meincke, Karl-Heinz, Kuck, Martin W, Bergmann   +2 more
openaire   +2 more sources

All-comer treatment with bioresorbable vascular scaffold

Wiener klinische Wochenschrift, 2016
Bioresorbable vascular scaffolds (BVS) could overcome drug-eluting stents (DES) drawbacks connected with their permanent presence in the vessel wall. Studies exploring the clinical use of BVS are limited to the patients presenting with noncomplex, short and stable lesions.
Matjaž, Bunc, Miha, Mrak, Peter, Rakovec   +2 more
openaire   +2 more sources